We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Fighting Sepsis: Drug ‘Revs Up’ the Immune System

News   Mar 09, 2018 | Original story from Washington University School of Medicine in St. Louis

 
Fighting Sepsis: Drug ‘Revs Up’ the Immune System

Richard Hotchkiss, MD, a professor of anesthesiology (left), and Jane Blood (right), a nurse manager in the Department of Anesthesiology's Division of Clinical and Translational Research, talk with Greg Porter, 34, of Nashville, Ill., who has recovered from sepsis. Porter participated in a clinical trial at Washington University School of Medicine in St. Louis. The researchers found that a drug that revs up the immune system holds promise in treating sepsis. Credit: Huy Mach

 
 
 

RELATED ARTICLES

Toxin in Bacteria Hijacks and Modifies Human Proteins

News

A team of scientists discovered that the toxin SidJ in Legionella bacteria enforces a unique modification on human proteins and helps legionella grow inside human cells.

READ MORE

Immune Cells Put Into Gear by Molecular "Clutch"

News

Proteins that drive activation of our immune response, by acting as a ‘clutch’ to move clusters of proteins within cells, have been identified. This could open opportunities to design immune cells to combat specific problems.

READ MORE

Targeting Enzyme “Bottleneck” Reveals Novel Anticancer Drug Strategy

News

The enzyme ribonucleotide reductase is a bottleneck for cancer cell growth. Scientists have now identified a way of targeting ribonucleotide reductase that may avoid the toxicity of previous approaches, informing focused drug discovery efforts.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE